These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 23223585)

  • 1. Screening for carbapenem-resistant Acinetobacter baumannii colonization sites: an implication for combination of horizontal and vertical approaches.
    Apisarnthanarak A; Warren DK
    Clin Infect Dis; 2013 Apr; 56(7):1057-9. PubMed ID: 23223585
    [No Abstract]   [Full Text] [Related]  

  • 2. Clonal spread of carbapenem resistant Acinetobacter baumannii in the patients and their environment at BMA Medical College and Vajira Hospital.
    Phumisantiphong U; Diraphat P; Utrarachkij F; Uaratanawong S; Siripanichgon K
    J Med Assoc Thai; 2009 Dec; 92 Suppl 7():S173-80. PubMed ID: 20232570
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Emergence of carbapenem resistance in Acinetobacter baumannii in the Czech Republic is associated with the spread of multidrug-resistant strains of European clone II.
    Nemec A; Krízová L; Maixnerová M; Diancourt L; van der Reijden TJ; Brisse S; van den Broek P; Dijkshoorn L
    J Antimicrob Chemother; 2008 Sep; 62(3):484-9. PubMed ID: 18477708
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Endemic carbapenem-resistant Acinetobacter baumannii in a Brazilian intensive care unit.
    dos Santos Saalfeld SM; Fukita Viana G; Dias Siqueira VL; Cardoso CL; Botelho Garcia L; Bronharo Tognim MC
    J Hosp Infect; 2009 Aug; 72(4):365-8. PubMed ID: 19541388
    [No Abstract]   [Full Text] [Related]  

  • 5. Emergence of resistance to carbapenems in Acinetobacter baumannii in Europe: clinical impact and therapeutic options.
    Kempf M; Rolain JM
    Int J Antimicrob Agents; 2012 Feb; 39(2):105-14. PubMed ID: 22113193
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Risk factors for acquired multidrug-resistant Acinetobacter baumannii colonization in respiratory intensive care unit].
    Wang HL; Sui WJ; Wang JR; Wang M; Huang YF; Gu HT; Pang J; Lu XX
    Zhonghua Yi Xue Za Zhi; 2012 Apr; 92(14):960-3. PubMed ID: 22781568
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Persistence of carbapenem-resistant Acinetobacter baumannii strains in an Italian intensive care unit during a forty-six month study period.
    Lambiase A; Piazza O; Rossano F; Del Pezzo M; Tufano R; Catania MR
    New Microbiol; 2012 Apr; 35(2):199-206. PubMed ID: 22707133
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of multidrug- and carbapenem-resistant Acinetobacter baumannii in Canada: results from CANWARD 2007.
    McCracken M; DeCorby M; Fuller J; Loo V; Hoban DJ; Zhanel GG; Mulvey MR
    J Antimicrob Chemother; 2009 Sep; 64(3):552-5. PubMed ID: 19578083
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterisation of carbapenem-resistant Acinetobacter calcoaceticus--A. baumannii complex isolates in a third-level hospital in Bogotá, Colombia.
    Saavedra SY; Nuñez JC; Pulido IY; Gonzalez EB; Valenzuela EM; Reguero MT; Mantilla JR; Arango AI; Bravo P
    Int J Antimicrob Agents; 2008 Apr; 31(4):389-91. PubMed ID: 18308519
    [No Abstract]   [Full Text] [Related]  

  • 10. Management and control of a carbapenem-resistant Acinetobacter baumannii outbreak in an intensive care unit.
    Alfandari S; Gois J; Delannoy PY; Georges H; Boussekey N; Chiche A; Meybeck A; Patoz P; Blondiaux N; Senneville E; Melliez H; Leroy O
    Med Mal Infect; 2014 May; 44(5):229-31. PubMed ID: 24840286
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Carbapenem-resistant Acinetobacter baumannii: diversity of resistant mechanisms and risk factors for infection.
    Kim YJ; Kim SI; Kim YR; Hong KW; Wie SH; Park YJ; Jeong H; Kang MW
    Epidemiol Infect; 2012 Jan; 140(1):137-45. PubMed ID: 21554783
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Colonization of a medical center in Southern Taiwan by epidemic strains of carbapenem- and multidrug-resistant Acinetobacter baumannii and the genetic organization of their integrons.
    Chen YS; Lin HH; Wu CH; Hsiao YS; Hsu NS; Chen YL
    Jpn J Infect Dis; 2009 Mar; 62(2):155-7. PubMed ID: 19305060
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of tigecycline in the control of a carbapenem-resistant Acinetobacter baumannii outbreak in an intensive care unit.
    Jamal W; Salama M; Dehrab N; Al Hashem G; Shahin M; Rotimi VO
    J Hosp Infect; 2009 Jul; 72(3):234-42. PubMed ID: 19493588
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Investigation of carbapenem-resistant Acinetobacter baumannii isolates in a district hospital in Taiwan.
    Chen CM; Liu PY; Ke SC; Wu HJ; Wu LT
    Diagn Microbiol Infect Dis; 2009 Apr; 63(4):394-7. PubMed ID: 19302926
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A multicenter study of risk factors and outcome of hospitalized patients with infections due to carbapenem-resistant Acinetobacter baumannii.
    Sheng WH; Liao CH; Lauderdale TL; Ko WC; Chen YS; Liu JW; Lau YJ; Wang LH; Liu KS; Tsai TY; Lin SY; Hsu MS; Hsu LY; Chang SC
    Int J Infect Dis; 2010 Sep; 14(9):e764-9. PubMed ID: 20646946
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antimicrobial resistance of Acinetobacter baumannii: six years of National Antimicrobial Resistance Surveillance Thailand (NARST) surveillance.
    Dejsirilert S; Tiengrim S; Sawanpanyalert P; Aswapokee N; Malathum K
    J Med Assoc Thai; 2009 Aug; 92 Suppl 4():S34-45. PubMed ID: 21294501
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Carbapenem-resistant Acinetobacter baumannii producing OXA-23 in Thailand.
    Niumsup PR; Boonkerd N; Tansawai U; Tiloklurs M
    Jpn J Infect Dis; 2009 Mar; 62(2):152-4. PubMed ID: 19305059
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clonal spread of carbapenem-resistant OXA-23-positive Acinetobacter baumannii in a Bulgarian university hospital.
    Stoeva T; Higgins PG; Bojkova K; Seifert H
    Clin Microbiol Infect; 2008 Jul; 14(7):723-7. PubMed ID: 18558947
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Risk factors for carbapenem-resistant Acinetobacter baumannii infections at a tertiary care hospital in New Caledonia, South Pacific.
    Le Hello S; Falcot V; Lacassin F; Mikulski M; Baumann F
    Scand J Infect Dis; 2010 Dec; 42(11-12):821-6. PubMed ID: 20560868
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epidemiological and clinical features associated with colonisation/infection by Acinetobacter baumannii with phenotypic heterogeneous resistance to carbapenems.
    Fernández-Cuenca F; Gómez-Sánchez M; Rodríguez-Baño J; Martínez-Martínez L; Vila J; Bou G; Pascual A
    Int J Antimicrob Agents; 2012 Sep; 40(3):235-8. PubMed ID: 22784855
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.